Crinetics Pharmaceuticals CEO Pizzuti Dana Sells Shares After Buying at Lower Price

Crinetics Pharmaceuticals, Inc. has recently disclosed that Dana Pizzuti, Chief Medical and Development Officer, has made a transaction involving the company's shares. Specifically, Pizzuti purchased 5,000 shares at a price of $16.89 per share on September 2, 2025, and subsequently sold an identical number of shares at $32.10 per share on the same day.

On September 2, 2025, Crinetics Pharmaceuticals, Inc. disclosed that Dana Pizzuti, Chief Medical and Development Officer, executed a significant transaction involving the company's shares. According to the SEC filing, Pizzuti purchased 5,000 shares at a price of $16.89 per share and subsequently sold an identical number of shares at $32.10 per share on the same day [1].

The transaction was part of a pre-established Rule 10b5-1 trading plan adopted on May 21, 2025. This plan allows officers and directors to sell shares automatically without violating insider trading laws. The pre-set plan ensures that the transactions are executed at regular intervals, reducing the risk of market manipulation [2].

Following the transaction, Pizzuti's beneficial ownership of Crinetics Pharmaceuticals' shares increased to 96,270 shares, with 84,042 shares derived from vested and unvested stock options remaining outstanding [1].

The transaction is viewed as procedural and not a sudden disposition. It indicates that Pizzuti converted equity into cash through a documented and automated plan, rather than an ad hoc sale. This adherence to insider-trading controls and disclosure rules reflects compliance with Section 16 reporting and safe-harbor procedures [2].

For investors, this clarification underscores the routine nature of the transaction and the company's commitment to transparency and regulatory compliance.

References:
[1] https://www.tradingview.com/news/tradingview:aa13ae7bbadcc:0-crinetics-pharmaceuticals-officer-sells-shares/
[2] https://www.stocktitan.net/sec-filings/CRNX/form-4-crinetics-pharmaceuticals-inc-insider-trading-activity-76e8779e6612.html